AIP
BHVN icon

ARS Investment Partners’s Biohaven BHVN Stock Holding History

ARS Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4M Sell
1,374,185
-4,643
-0.3% -$50K 0.89% 31
2026
Q1 		$11.7M Buy
1,378,828
+139,228
+11% +$1.52M 0.61% 39
2025
Q4 		$14M Buy
1,239,600
+137,051
+12% +$1.7M 0.82% 32
2025
Q3 		$16.5M Sell
1,102,549
-85,577
-7% -$1.25M 1.09% 29
2025
Q2 		$16.8M Buy
1,188,126
+148,255
+14% +$2.64M 1.22% 30
2025
Q1 		$38.8M Sell
1,039,871
-841
-0.1% -$29.7K 3.51% 5
2024
Q4 		$38.9M Buy
1,040,712
+10,473
+1% +$489K 3.5% 6
2024
Q3 		$51.5M Buy
1,030,239
+89,727
+10% +$3.49M 4.61% 2
2024
Q2 		$32.6M Buy
940,512
+304,141
+48% +$12M 3.12% 10
2024
Q1 		$34.8M Buy
636,371
+2,407
+0.4% +$119K 3.47% 9
2023
Q4 		$27.1M Buy
633,964
+9,615
+2% +$299K 3.01% 10
2023
Q3 		$16.2M Buy
624,349
+910
+0.1% +$18.9K 2.01% 18
2023
Q2 		$14.9M Buy
623,439
+42,125
+7% +$725K 1.74% 19
2023
Q1 		$7.94M Buy
581,314
+17,075
+3% +$272K 0.95% 33
2022
Q4 		$7.83M Buy
+564,239
New +$7.97M 1.04% 29

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ARS Investment Partners's BHVN Position: Q2 2026 in Review

ARS Investment Partners reduced its Biohaven (BHVN) stake by 0.34% in Q2 2026, selling an estimated $50K and leaving 1,374,185 shares worth $20.4M. The position accounts for 0.89% of the portfolio, ranked #31.

ARS Investment Partners first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $51.5M in Q3 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • ARS Investment Partners held 1,374,185 shares of Biohaven worth $20.4M as of Q2 2026.
  • ARS Investment Partners sold 4,643 Biohaven shares in Q2 2026, an estimated $50K.
  • Biohaven made up 0.89% of ARS Investment Partners's portfolio in Q2 2026, its #31 holding.
  • ARS Investment Partners first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • ARS Investment Partners's Biohaven position peaked at $51.5M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.